CNNW The Situation Room March 25, 2013
. is it time for the buried lead. that's what we call stories we think aren't getting enough play. the supreme court is taking up a case that could impact anyone who's tried to save a little money on prescription drugs. at issue is a practice called pay to delay. it's when pharmaceutical companies pay the makers of generic drugs to hold off on putting those cheaper drugs on the mark. the ftc says the practice is not only illegal, it hurts consumers but drug companies argue that the system is a way to work around patent disputes. the high court is expected to rule on the issue this ...